<DOC>
	<DOCNO>NCT00577356</DOCNO>
	<brief_summary>The purpose study find effect , good bad , combination docetaxel CG1940/CG8711 ( immunotherapy drug ) destroy prostate cancer removal prostate ( prostatectomy ) .</brief_summary>
	<brief_title>Docetaxel Immunotherapy Prior Prostatectomy High-Risk Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Patients must clinical stage 13 disease radiographic evidence metastatic disease Nomogram Prediction : Patients must Kattan nomogram predict probability free biochemical progression 5 year surgery &lt; 60 % . Concurrent prior treatment radiation , cytotoxic biologic therapy prostate cancer , prior hormonal therapy ( except finasteride dutasteride obstructive voiding symptom ) Male patient unwilling use effective mean contraception exclude . Contraception continue 3 month treatment . Prior malignancy exclude patient . ( Patients active cancer undergo active treatment ) . The Principal Investigator make final decision regard eligibility since end point pathological complete response .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>